Evidence map›Paper›PMID 41866527›Full record

ArticleBiology of sex differences2026

Sex-specific dynamics of MASLD reveal early hepatic and extrahepatic metabolic deterioration in females despite long-term protection.

Maria Repollés-de-Dalmau, Anna Marsal-Beltran, Catalina Núñez-Roa, Joan Vendrell, Victòria Ceperuelo-Mallafré, Sonia Fernández-Veledo

Abstract read
In one paragraph

Article in Biology of sex differences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Repollés-de-Dalmau *DIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain.
Anna Marsal-Beltran *DIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain.
Catalina Núñez-RoaDIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain.
Joan VendrellDIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain.
Victòria Ceperuelo-MallafréDIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain.
Sonia Fernández-VeledoDIAMET Research Group, Institut de Recerca Biomèdica Catalunya Sud (Formerly Institut d'Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona, 43005, Spain. sonia.fernandez@irbcatsud.cat.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2023 FI-1 00035Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CB07708/0012European Foundation for the Study of Diabetes PV22043SGeneralitat de Catalunya 2021 SGR 00829Generalitat de Catalunya 2021 SGR 01409Instituto de Salud Carlos III PI20/00095Instituto de Salud Carlos III PI20/00338'la Caixa' Foundation LCF/PR/ HR20/52400013Ministerio de Ciencia e Innovación CNS2023-143826Ministerio de Ciencia e Innovación FPU20/05633Ministerio de Ciencia e Innovación PID2021-122480OB-100Societat Catalana de Digestologia Research initiation grant
6 · The paper itself

Abstract

backgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic condition characterized by hepatic fat accumulation and systemic metabolic dysfunction. MASLD exhibits clear sex differences, yet the mechanisms underlying these disparities remain poorly defined.

methodsTo investigate the early temporal dynamics of MASLD, male and female mice were fed a choline-deficient, methionine-restricted (0.1%) high-fat (61%) diet (CDAHFD; characterized by impaired hepatic lipid export and enhanced lipotoxic stress) for two weeks, enabling assessment of initial metabolic responses.

resultsDespite their presumed protection, females developed an exacerbated hepatic phenotype accompanied by intestinal remodeling and compromised barrier integrity. In contrast, males displayed early weight loss and improved glucose tolerance, alongside reduced hepatic transcriptional changes indicative of adaptive metabolism. Additionally, sex-specific hypothalamic responses were observed, with males showing reduced expression of microglial homeostatic markers, increased inflammation, and alterations in energy balance-related signaling, consistent with neuroimmune modulation. These responses were paralleled by sex-dependent alterations in adipose tissue, including early adipocyte remodeling and distinct transcriptional changes, which were predominantly consistent with baseline sex differences and therefore suggest a limited contribution of this tissue to the early diet-induced metabolic divergence. Importantly, these early sex-dependent adaptations were not sustained over time, as prolonged CDAHFD (14 weeks) resulted in a shift towards a more sever inflammatory and fibrotic hepatic phenotype in males, while females exhibited relative preservation of hepatic metabolic function and attenuation of intestinal alterations.

conclusionsThese findings demonstrate that sexual dimorphism in MASLD arises early and evolves dynamically, with females mounting an acute metabolic and intestinal stress response, whereas males activate compensatory pathways that preserve metabolic homeostasis. These results highlight sex-specific trajectory in MASLD progression and emphasize the need for integrative approaches to unravel its pathophysiology.

Indexed as

Fatty LiverLiverNon-alcoholic Fatty Liver DiseaseSex CharacteristicsAdipose TissueAnimalsDiet, High-FatFemaleMaleMiceMice, Inbred C57BLCDAHFDGutSexual dimorphismSteatohepatitis

Identifiers

PMID41866527
PMCPMC13130735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.